Serum Proteins C and S Levels As Early Biomarkers for Kidney Dysfunction in Hemophilic Patients

Overview

Journal Afr Health Sci

Date 2019 Jan 4

PMID 30603001

Citations 2

Authors

Maryam A Al-Ghamdi

Etimad A Huwait

Taha A Kumosani

M Qari

Said S Moselhy

Afnan T Kumosani

Affiliations

Soon will be listed here.

Abstract

Background: Hemophilia is an inherited genetic disease characterized by the inability to coagulate blood after injury. The rationale of the current study was to evaluate serum proteins S and C and correlate to kidney function test in hemophilic patients for early diagnosis of abnormality in renal function.

Subjects And Methods: This study was conducted on 80 males subjects divided into four groups. Group I: Control: Healthy subjects. Group II: Renal dysfunction (serum Creatinine >2mg/dl): Group III: Hemophilic patients. Group IV: Hemophilic patients with renal disorder. Serum urea, creatinine, sodium, potassium, protein C and protein S level were determined.

Resuts: Protein C and S levels showed a significant decrease in hemophilic/and with renal dysfunction (P < 0.001, p<0.001). The level of plasma protein C and S levels were positively correlated with increased urinary albumin (P < 0.01). Urinary albumin was increased about 15 folds in hemophilic patients with renal dysfunction and nephrotic patients as compared with the control group. The cut-off value in 90% patients at the hemophilic patients with renal dysfunction 70%. Positive correlations were observed between urinary albumin (r=0.66), and creatinine (r=0.73).

Conclusion: These biomarkers showed good predictive values with regard to ROC-AUC (0.41 and 0.75 for Proteins C and S, respectively).

Citing Articles

Emicizumab-mediated hemostatic function assessed by thrombin generation assay in an in vitro model of factor VIII-depleted thrombophilia plasma.

Yada K, Ogiwara K, Shimonishi N, Nakajima Y, Soeda T, Kitazawa T Int J Hematol. 2023; 119(2):109-118.

PMID: 38112996 DOI: 10.1007/s12185-023-03683-y.

Progress in infections, reproductive health and non-communicable diseases.

Tumwine J Afr Health Sci. 2019; 18(3):i-iv.

PMID: 30603019 PMC: 6306991. DOI: 10.4314/ahs.v18i3.1.

References

Ruotsalainen V, Ljungberg P, WARTIOVAARA J, Lenkkeri U, Kestila M, Jalanko H . Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proc Natl Acad Sci U S A. 1999; 96(14):7962-7. PMC: 22170. DOI: 10.1073/pnas.96.14.7962. View

Kotajima N, Kimura T, Kanda T, Obata K, Kuwabara A, Fukumura Y . Type IV collagen as an early marker for diabetic nephropathy in non-insulin-dependent diabetes mellitus. J Diabetes Complications. 2000; 14(1):13-7. DOI: 10.1016/s1056-8727(00)00064-7. View

Beltcheva O, MARTIN P, Lenkkeri U, Tryggvason K . Mutation spectrum in the nephrin gene (NPHS1) in congenital nephrotic syndrome. Hum Mutat. 2001; 17(5):368-73. DOI: 10.1002/humu.1111. View

. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39(2 Suppl 1):S1-266. View

Hinokio Y, Suzuki S, Hirai M, Suzuki C, Suzuki M, Toyota T . Urinary excretion of 8-oxo-7, 8-dihydro-2'-deoxyguanosine as a predictor of the development of diabetic nephropathy. Diabetologia. 2002; 45(6):877-82. DOI: 10.1007/s00125-002-0831-8. View

MAMMEN E, Thomas W, SEEGERS W . Activation of purified prothrombin to autoprothrombin I or autoprothrombin II (platelet cofactor II or autoprothrombin II-A). Thromb Diath Haemorrh. 1960; 5:218-49. View

Beauchamp N, Dykes A, Parikh N, Tait R, Daly M . The prevalence of, and molecular defects underlying, inherited protein S deficiency in the general population. Br J Haematol. 2004; 125(5):647-54. DOI: 10.1111/j.1365-2141.2004.04961.x. View

Nicolaes G, Dahlback B . Congenital and acquired activated protein C resistance. Semin Vasc Med. 2004; 3(1):33-46. DOI: 10.1055/s-2003-38331. View

Coresh J, Byrd-Holt D, Astor B, Briggs J, Eggers P, Lacher D . Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol. 2004; 16(1):180-8. DOI: 10.1681/ASN.2004070539. View

10.

de Zeeuw D, Hillege H, de Jong P . The kidney, a cardiovascular risk marker, and a new target for therapy. Kidney Int Suppl. 2005; (98):S25-9. DOI: 10.1111/j.1523-1755.2005.09805.x. View

11.

Mosnier L, Griffin J . Protein C anticoagulant activity in relation to anti-inflammatory and anti-apoptotic activities. Front Biosci. 2006; 11:2381-99. DOI: 10.2741/1977. View

12.

Levey A, Andreoli S, DuBose T, Provenzano R, Collins A . CKD: common, harmful, and treatable--World Kidney Day 2007. Am J Kidney Dis. 2007; 49(2):175-9. DOI: 10.1053/j.ajkd.2006.12.013. View

13.

Garcia de Frutos P, Fuentes-Prior P, Hurtado B, Sala N . Molecular basis of protein S deficiency. Thromb Haemost. 2007; 98(3):543-56. View

14.

Aaltonen P, Holthofer H . The nephrin-based slit diaphragm: new insight into the signalling platform identifies targets for therapy. Nephrol Dial Transplant. 2007; 22(12):3408-10. DOI: 10.1093/ndt/gfm403. View

15.

Castoldi E, Hackeng T . Regulation of coagulation by protein S. Curr Opin Hematol. 2008; 15(5):529-36. DOI: 10.1097/MOH.0b013e328309ec97. View

16.

Goldenberg N, Manco-Johnson M . Protein C deficiency. Haemophilia. 2009; 14(6):1214-21. DOI: 10.1111/j.1365-2516.2008.01838.x. View

17.

Levey A, Stevens L, Schmid C, Zhang Y, Castro 3rd A, Feldman H . A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150(9):604-12. PMC: 2763564. DOI: 10.7326/0003-4819-150-9-200905050-00006. View

18.

Rouse R, Zhang J, Stewart S, Rosenzweig B, Espandiari P, Sadrieh N . Comparative profile of commercially available urinary biomarkers in preclinical drug-induced kidney injury and recovery in rats. Kidney Int. 2010; 79(11):1186-97. DOI: 10.1038/ki.2010.463. View

19.

Broedbaek K, Weimann A, Stovgaard E, Poulsen H . Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine as a biomarker in type 2 diabetes. Free Radic Biol Med. 2011; 51(8):1473-9. DOI: 10.1016/j.freeradbiomed.2011.07.007. View

20.

Long G, Marshall A, Gardner J, Naylor S . Genes for human vitamin K-dependent plasma proteins C and S are located on chromosomes 2 and 3, respectively. Somat Cell Mol Genet. 1988; 14(1):93-8. DOI: 10.1007/BF01535052. View